Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > We have likely started to turn the corner

<< Previous

Bullboard Posts

Next >>

Comment by longterm56on Oct 16, 2020 5:29pm

141 Views

Post# 31732734

RE:RE:We have likely started to turn the corner

Wow, quite a position, realitycheck. I still am amazed that contributors to this board make up ~33% of the ownership ... that is just astounding!! Maybe its time to throw our weight around abit. It seems we should qualify for a private meeting where we ask the questions rather than the analysts.

-LT

realitycheck4u wrote: Sorry for the few spelling mistakes...I cut and pasted using my phone and unfortunately didn't catch these as I was typing.

realitycheck4u wrote: Not feeling great with how badly the call went this week, however I have to assume that our leaders now have finally realized their failings - and that they realize that they must now rectify them. They simply have no idea how badly they explain things and how terribly they instill crystal clear confidence in their plans.

As a significant shareholder with a little less than 1% ownership now, I am mindful of the work they have cut out for them. And I expect them to deliver.

Having been a hot head on this company for a long time, I do think that they have potential. But, it will only get there on the valuation perspective with very significant changes as to how they are articulating the story. This is where they have failed time and time and time again.

I think we will see these changes soon enough. If they cannot do this, Paul must make heads roll andctually remove/replace people and/or if he does not, we must make those changes for the company. He must no that there are no more excuses and no more tie or free passes. He has to make changes. He has failed shareholders under his leadership thus far, all the while advancing the story (but not explaining it properly) and the potential now at this point in time is just a small fraction of where it should be today. We should have a market cap of 500M to 750M now. Next week and the next several months are critical. They should hire outside services now to bring them up to speed and to explain the story and they must stop leaving Leah to figure it out for them. She needs help. Paul needs help. THTX needs help. They have proven they cannot do this. So, get help. Please.